Abstract. Alzheimer's disease (AD) is increasingly viewed as a disease of synapses. Loss of synapses correlates better with cognitive decline than amyloid plaques and neurofibrillary tangles, the hallmark neuropathological lesions of AD. Soluble forms of amyloid-␤ (A␤) have emerged as mediators of synapse dysfunction. A␤ binds to, accumulates, and aggregates in synapses. However, the anatomical and neurotransmitter specificity of A␤ and the amyloid-␤ protein precursor (A␤PP) in AD remain poorly understood. In addition, the relative roles of A␤ and A␤PP in the development of AD, at pre-versus post-synaptic compartments and axons versus dendrites, respectively, remain unclear. Here we use immunogold electron microscopy and confocal microscopy to provide evidence for heterogeneity in the localization of A␤/A␤PP. We demonstrate that A␤ binds to a subset of synapses in cultured neurons, with preferential binding to glutamatergic compared to GABAergic neurons. We also highlight the challenge of defining pre-versus post-synaptic localization of this binding by confocal microscopy. Further, endogenous A␤ 42 accumulates in both glutamatergic and GABAergic A␤PP/PS1 transgenic primary neurons, but at varying levels. Moreover, upon knock-out of presenilin 1 or inhibition of ␥-secretase A␤PP C-terminal fragments accumulate both pre-and post-synaptically; however earlier pre-synaptically, consistent with a higher rate of A␤PP processing in axons. A better understanding of the synaptic and anatomical selectivity of A␤/A␤PP in AD can be important for the development of more effective new therapies for this major disease of aging.
INTRODUCTION
Synapses are a unique characteristic of nerve cells and are increasingly seen as critical sites of pathogenesis in neurodegenerative diseases of aging. In Alzheimer's disease (AD), it has long been known that loss of synapses is a better brain correlate of cognitive decline than the number of amyloid plaques or neurofibrillary tangles [1, 2] , the two neuropathological hallmark lesions. The high metabolic demands of the brain relate to the large amount of energy consumed by synaptic function. It has been hypothesized that this high-energy consumption at synapses could lead to their age-related vulnerability from reactive oxidant species [3, 4] . Further, synaptic activity stimulates amyloid-␤ (A␤) generation and secretion [5] , as well as degradation [6] . The observation that the anatomy of amyloid plaque pathology in the brain resembles metabolic activity in the default network has led to a hypothesis that synaptic activity via stimulated generation and secretion of A␤ may drive A␤ accumulation and thereby AD pathogenesis [7] . Several other findings point to synapses as critical mediators of the disease. A␤ in brain accumulates and aggregates particularly in synaptic terminals with A␤ pathogenesis, which occurs even prior to plaques [8, 9] . A␤ selectively binds to synapses when added to cultured neurons [10] . Further, A␤ oligomers in synaptosomes were shown to be increased in early AD but not in brains of cognitively normal individuals who showed amyloid pathology [11] .
In contrast to several other neurodegenerative diseases, such as Parkinson's disease, the anatomic and neurotransmitter specificity of synaptic damage in AD remains poorly understood. Neurochemical and neuropathological studies on postmortem brain have provided some insights into the selective vulnerability in AD with evidence for preferential loss of the neurotransmitter acetylcholine and basal forebrain cholinergic neurons [12] [13] [14] [15] . Region-specific accumulation of intraneuronal A␤ 42 was noted particularly in AD vulnerable neurons, such as layer II neurons of entorhinal cortex (ERC), CA1 pyramidal neurons of hippocampus and basal forebrain cholinergic neurons, which appeared to increase with age, but then decreased with severity of dementia and plaque deposition [16] . More recently, intracellular A␤ 42 immunoreactivity was more carefully described in the cholinergic neuronal population in the basal forebrain and shown to be stronger compared to in the pyramidal neurons of the superior temporal and insular cortices [17] . Moreover, it is well known that tangle pathology in the hippocampal formation initiates in a set of projection neurons in layer II of ERC that then degenerate early in the disease [18, 19] . Early accumulation of A␤ 42 in Reelin-positive neurons of ERC layer II was recently reported [20] . While these glutamatergic Reelinpositive ERC layer II neurons are destined for early tangle pathology and loss in AD, initial plaques in the hippocampus develop in their terminal fields in the outer molecular layer of the dentate, providing an explanation for the apparent anatomical disconnect between amyloid and tau pathologies. Studies on the subcellular distribution of intracellular A␤ accumulation in brain have emphasized post-synaptic accumulation and aggregation of A␤, although marked pre-synaptic localization was also reported [8] . When it comes to extracellular A␤, it was shown that added exogenous oligomeric A␤ appears to bind particularly to the post-synapse, where it overlapped with the post-synaptic marker PSD-95 [10] , although this A␤ did not bind equally to all neurons.
Further evidence for such selectivity of A␤ came from a report showing that not all neurons are equally sensitive to A␤-induced synapse damage [21] .
It also remains unclear whether amyloid-␤ protein precursor (A␤PP) trafficking and generation of A␤, occurs more in pre-compared to post-synaptic terminals [22, 23] . A␤PP is known to be transported down both axons and dendrites and the proteases that cleave A␤PP to generate A␤ have been localized to both pre-and post-synaptic sites. One recent report in primary neurons showed that one genetic risk factor for late onset AD, Bin1, promoted axonal A␤ generation in endosomes, while another genetic risk factor, CD2AP, promoted A␤ generation in dendrites [24] . Evidence also supports pre-synaptic A␤ generation in certain anatomical pathways such as the mossy fibers of the hippocampus, given accumulation of BACE1 and A␤ at these sites [25] . More than 150 familial AD-causing mutations in presenilin 1 (PS1), critical for the final cleavage to generate A␤, have been identified and approximately 10 additional mutations have been found in the homologous gene PS2 (http://www.molgen.ua.ac.be/ADMutations). Conditional knock-out of PS1 was reported to lead to accumulation of A␤PP CTFs to pre-synaptic sites of CA1 in hippocampus [26] . Interestingly, a recent report highlighted that PS1 and PS2 appear to differ in their trafficking and relative cleavage of A␤PP in axons compared to dendrites [27] . Thus, current evidence supports that at anatomical, neuron-type and subcellular levels, there are differences in A␤PP processing, A␤ generation and AD-related pathogenesis.
Here we set out to provide new evidence pertaining to the anatomic and synaptic selectivity of A␤PP processing and A␤ accumulation. We also aim to highlight work that will be necessary to better define the subcellular site of A␤ involvement within neurons as well as the selective vulnerability of certain neurons in AD.
MATERIALS AND METHODS

Cell culture
Primary neuronal cultures were generated from B6.Cg-Tg(A␤PP swe,PSEN1dE9) 85Dbo/Mmjax mice (A␤PP/PS1) AD transgenic (tg) and wildtype (wt) mouse embryos. The A␤PP sequence in A␤PP/PS1 encodes a chimeric mouse/human A␤PP (Mo/Hu A␤PP 695swe) that was humanized by modifying three amino acids, and introducing the Swedish AD mutation. The PS1 sequence encodes human presenilin 1 lacking exon 9 (dE9) that models ADassociated mutations in PS1. Both A␤PPswe and PS1 are independently controlled by the prion protein promoter. Primary neuronal cultures were prepared from cortices including hippocampi of embryonic day 15 embryos as previously described [9] . In brief, E15 brain tissue was dissociated by trypsinization and trituration in DMEM with 10% fetal bovine serum (Gibco). Dissociated neurons were cultured on poly-D-lysine (Sigma) coated plates or glass coverslips (Bellco Glass Inc.) and were maintained in neurobasal medium (Gibco), B27 supplement (Gibco), glutamine (Invitrogen) and antibiotics (ThermoScientific). All animal experiments were approved by the Animal Ethical Committee of Lund University.
Mice
PS1 cKO; A␤PP Tg mice were generated as described [26] .
Cell immunofluorescence
Cultured neurons at 12 and 19 DIV or N2a cells were fixed in 4% paraformaldehyde (PFA) in PBS with 0.12 M sucrose for 20 min, permeabilized and blocked in PBS containing 2% normal goat serum (NGS), 1% bovine serum albumin, and 0.1% saponin at room temperature for 1 h, and then immunolabeled in 2% NGS in PBS overnight at 4 • C. After appropriate washing, coverslips were mounted with SlowfadeGold (Invitrogen). For PSD-95 labeling cells were fixed 10 min in 4% PFA in PBS with 0.12 M sucrose followed by 5 min in ice-cold methanol in -20 • C. Immunofluorescence was examined with epifluorescent microscope (Olympus IX70) (Fig. 1A  only) or by confocal laser scanning microscopy (Leica TCS SP8). In multiple label experiments, channels were imaged sequentially to avoid bleedthrough. Images were taken with Leica Confocal Software and analyzed with ImageJ or Imaris x64 8.3. Colocalization analysis was performed with Imaris with automatic thresholding based on point spread function width. For ImageJ analysis of localization of ␥-secretase cleaved A␤PP, thresholds were set by automatic thresholding by default on confocal images in the MAP2 or tau-1 channel. The mean intensity of the 369 channel was subsequently measured in the pixels that were above threshold in the MAP2 or tau-1 channel, respectively. Aβ A␤ 1-42 peptides (Tocris) or A␤ HiLyte™ Fluor 555 labeled peptides (A␤555) (AnaSpec) were reconstituted in DMSO to 250 M, sonicated for 10 min and followed by 15 min of centrifugation at 12k rpm before adding the supernatant to the culture media in depicted final concentrations.
Antibodies and reagents
The following antibodies were used: 369 [28] 
Colocalization analysis
Colocalization analysis was performed using Imaris software. The colocalization channel displays the intensity of colocalized voxels as the square root of the product of the intensities of the original channels, hence the brightest pixels in the colocalization channel represent the pixels with the highest colocalization. Under conditions of proportional codistribution, the points of the scatter plot cluster around a straight line. However, lack of colocalization is reflected by distribution of points onto two separate groups, each showing varying levels of one probe with little or no signal from the other probe. Quantification of colocalization was done with automatic thresholding and was reported as percentage of colocalized material above threshold. Pearson's correlation coefficient (PCC) is based on an algorithm developed by Costes and Lockett at the National Institute of Health, NCI/SAIC [29] . PCC values range from 1 for two images whose fluorescence 42 and the added human synthetic A␤ , displays two large neurons in each of these images. However, the exogenously added human A␤ , recognized by antibody 6E10 (right panels), accumulates predominantly only in one of the two neurons, including their processes. Note the brighter labeling with the high affinity antibody 6E10 of only one of the two neurons in the right image panels. Scale bars 50 m. B-C) Accumulation of exogenously added A␤ 1-42 for 30 min is more pronounced in excitatory CamKII-positive compared to inhibitory GAD67-positive neurons. B) A␤ accumulation in some but not all, and not exclusively in, neurons labeled with CamKII␣. Higher magnification images (right) with A␤ in CamKII␣-positive synaptic terminals that appear more consistent with dendritic spines. C) A␤ was not seen accumulating in any GAD67-positive neurons.
intensities are perfectly linearly related, to -1 for two images whose fluorescence intensities are perfectly, but inversely, related to one another. Values near zero reflect distributions that are uncorrelated with one another. Because PCC subtracts the mean intensity from the intensity of each pixel value, it is independent of signal levels and background. Thus, PCC can be measured without any form of preprocessing, making it relatively safe from user bias. Manders' Colocalization Coefficients (MCC) is the fraction of the total probe fluorescence of one protein that colocalizes with the fluorescence of a second protein.
MCC strictly measures co-occurrence independent of signal proportionality. It is necessary to first eliminate the background and this is done automatically in Imaris by the method developed by Costes [29] .
Immunogold electron microscopy
Paraffin embedded brain sections (10 m) of PS1cKO; A␤PP Tg mice were deparaffinized, alcohol-dehydrated, and free-floating sections were incubated with 369 antibody (A␤PP C-terminal epitope) by the immunogold-silver procedure with goat anti-rabbit IgG conjugated to 1 nm gold particles (Amersham Biosciences, Arlington, IL) in 1.01% gelatin and 0.08% bovine serum albumin in PBS. Transmission electron microscopy was performed on a Philips CM10 electron microscope. Immunogold electron microscopic analysis were performed as previously described [8] .
Statistical analysis
Statistical analysis was performed with PRISM 6 software (Graph-Pad Software, San Diego, CA, USA) by using unpaired t-test. Data are expressed as mean ± SD. Differences were considered significant at *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
RESULTS
Selective binding and internalization of exogenously added Aβ
Binding and uptake of synthetic human A␤ (huA␤ ) added to primary mouse neurons in culture is remarkably heterogeneous for different neurons. As an example, two neurons side-by-side can show completely different abilities to accumulate exogenous huA␤ added for 24 h and 48 h to the culture medium (Fig. 1A) . While the whole dendritic tree is labeled by huA␤ in a punctate pattern in one neuron, an adjacent neuron (white arrow) is completely devoid of huA␤ along its processes. In some cases, neurons negative for huA␤ in their dendrites, do however show strong huA␤ -signal in their cell bodies (Fig. 1A) . In general, huA␤ accumulation in the cell body increases with time, with more neurons showing large amounts of huA␤ in their cell bodies at 48 h compared to 24 h.
Neurons can broadly be classified as either excitatory or inhibitory. We therefore first asked whether A␤ binds preferentially to certain types of neurons, based on whether they express excitatory or inhibitory markers. We first confirmed that primary neurons incubated with fluorescently tagged A␤ 1-42 (A␤555) for 30 min also preferentially accumulated only in select neurons consistent with the results obtained with untagged human A␤ shown in Fig. 1A . Immunofluorescent labeling of CAMKII␣, which recognizes the majority of glutamatergic neurons, shows that some but not all of the A␤555-positive neurons co-label for CAMKII␣. However, not all CAMKII␣-positive cells have strong A␤555-labeling. Figure 1B shows a CAMKII␣-positive cell with prominent A␤555-labeling along its processes, with marked labeling also of terminals, which appear consistent with dendritic spines (Fig. 1B higher magnification) . In contrast, no overlap was observed upon labeling A␤555-treated cells with GAD67, a marker for GABAergic neurons, despite GAD67-positive processes often being very close or intertwined with A␤555-positive processes (Fig. 1C) .
Untreated transgenic A␤PP/PS1 primary neurons in culture also display varying levels of endogenous A␤ 42 (Fig. 2) , even though they all overexpress A␤PPswe under the prion protein promoter. We therefore asked whether the excitatory or inhibitory type of individual neurons could affect the intracellular A␤ 42 levels. All CAMKII␣-positive cells (white filled arrows) have high levels of A␤ 42 , with 27% of all A␤ 42 positive cells being CAMKII␣-positive. However so do many, but not all, CAMKII␣-negative cells as well (black arrows) ( Fig. 2A, B) . Many GAD67-positive neurons show similar high levels of A␤ 42 to CAMKII␣-positive neurons; in total about 26% of all A␤ 42 positive cells were GAD67-positive (Fig. 2C) . There was also variability in labeling of endogenous A␤ 42 in somatostatin positive inhibitory neurons, which represent a subgroup of the GAD67-positive GABAergic neurons, with some showing low levels of A␤ 42 , with 2% of all A␤ 42 positive cells being somatostatin positive and 44% of all somatostatin positive cells being positive for A␤ 42 (Fig. 2D) .
The pattern of Aβ accumulation in neurons is more consistent with dendritic labeling
To determine whether added human A␤ 1-42 preferentially localizes to axons or dendrites, primary neurons were treated with 0.5 M fluorescentlytagged A␤ 1-42 (A␤555) for 30 min and subsequently labeled with tau-1 and MAP2 antibodies to label axons and dendrites, respectively (Fig. 3) . A␤555 did not clearly co-localize well with either tau-1 or MAP2, which could be due to these proteins not extending fully into synaptic terminals. However, the overall pattern of A␤ labeling appeared more similar to that observed with dendritic MAP2 rather than axonal tau-1 labeling. It appeared that A␤ was present near to MAP2, or between MAP2 and tau-1 positive processes, suggesting accumulation at synaptic terminals and in particular dendritic spines.
Aβ binds and accumulates at pre-and post-synaptic sites
To test if A␤ 1-42 is accumulating at synapses and whether it has a preference to the pre-or post-synaptic side, neurons were treated with A␤555 for 30 min and labeled with two sets of pre-and post-synaptic markers, respectively: synapsin I and PSD-95 (Fig. 4A ) or synaptophysin and drebrin (Fig. 4B) . A␤555 was colabeled with one pre-and one post-synaptic marker on the same coverslip. Two different sets of pre-and post-synaptic markers were used, since the intensity and prevalence of a specific marker could potentially influence the colocalization analysis. In the colocalization images (Fig. 4A, B , right panel) the brightest pixels in the colocalization channel represent the pixels with the highest colocalization. The scatter plots (Fig. 4C, D) show the intensity of the A␤ 1-42 channel plotted against the intensity of the respective pre-or post-synaptic channel for each pixel. Quantification of colocalization revealed that there is no significant difference in the percentage of material above threshold colocalized with A␤555 between pre-and post-synaptic markers (Fig. 4C,  D) . PCC values between PSD-95 and synapsin I, and drebrin and synaptophysin, respectively, are not significantly changed (Fig. 4E, F) . MCC values of A␤ 1-42 are also not significantly changed between pre-and post-synaptic markers (Fig. 4E, F) . Taken together, these results with two different sets of preand post-synaptic markers support that A␤555 does not have a clear-cut preference for either the pre-or post-synaptic site.
γ-secretase inhibition leads to earlier AβPP CTF accumulation at pre-than post-synaptic sites
The complex subcellular localization and anatomy in the brain of A␤PP processing is further evident with the anatomically and pre-versus postsynaptic selective accumulation of A␤PP CTFs with ␥-secretase inhibition or absence of PS1. Accumulation of A␤PP CTFs in pre-synaptic compartments in the CA1 region of hippocampus was previously reported in conditional PS1 knock-out mice over-expressing A␤PP (cKO; A␤PP Tg mice) [26] . However, there is an anatomy to this A␤PP CTF accumulation, since in the CA3 region of hippocampus A␤PP CTFs mainly accumulate in post-rather than pre-synaptic compartments in these PS1 cKO; A␤PP Tg mice (Fig. 5A ). This shows that A␤PP CTF accumulation due to lack of PS1 activity can occur both at the pre-and post-synaptic sites. To further explore this selective accumulation of CTF, we next used immunofluorescent labeling of A␤PP/PS1 cortical, including hippocampal, primary neurons treated with the ␥-secretase inhibitor DAPT. Of note, 17 h of DAPT treatment revealed A␤PP CTF-accumulation with the C-terminal specific A␤PP antibody 369 in both pre-and post-synaptic compartments as labeled with synaptophysin and PSD-95, respectively. However, at early time points A␤PP CTFs upon DAPT treatment were evident only in pre-synaptic compartments. Specifically, after 2 h with DAPT there was a marked increase of A␤PP CTFs in pre-synaptic compartments of treated compared to untreated neurons (223% of untreated control, p < 0.0001). After 17 h of DAPT treatment, A␤PP CTFs were further increased in pre-synaptic compartments (324% of untreated control, p = 0.0001) and were now also evident in post-synaptic compartments (202% of untreated control, p = 0.02) (Fig. 5B, C) . Further, labeling with markers for axons and dendrites indicated that A␤PP CTFs accumulate in a pattern more consistent with axons in neurons treated with DAPT for 17 h (Supplementary Figure 2 ). Taken together these data support the conclusion that ␥-secretase cleavage of A␤PP, as measured by A␤PP CTF-accumulation after ␥-secretase inhibition, occurs earlier and/or to a larger extent in pre-synaptic compartments compared to post-synaptic compartments in cortical primary neurons.
DISCUSSION
In the current study, we discuss and further explore the more complex anatomy in brain and subcellular localization in neurons of A␤ and A␤PP. Specifically, we show that exogenous A␤ accumulates in a punctate pattern along processes in a subset of CamKII-positive neurons but not in GAD67-positive neurons. We also demonstrate that exogenous A␤ does not clearly have a selective preference to either the pre-or post-synaptic side in cultured neurons. However, the overall pattern of exogenous A␤ accumulation in neurons is more consistent with dendritic labeling. Finally, we show with EM that ␥-secretase inhibition leads to A␤PP CTF accumulation at either the pre-or post-synaptic site depending on the anatomical localization in the hippocampus.
Amyloid deposition in the AD brain during the progression of the disease generally follows a similar pattern [30, 31] , although variants occur such as the visual variant of AD [32] . It is possible that the specific vulnerability of certain brain areas and neurons in the AD brain are attributed to a preference of A␤ to accumulate in and/or bind to specific types of neurons. In fact, laser capture micro-dissection of individual neurons pooled from human brains showed that CA1 pyramidal neurons show much higher levels of endogenous A␤ 42 compared to cerebellar Purkinje neurons [33] . Moreover, it was also shown that less A␤ binds to cerebellar compared to cortical synaptosomes [34] . We show that added human A␤ only accumulates in a subset of neurons in culture initially in a punctate pattern along their processes. This corroborates a previous study where A␤ diffusible oligomers (ADDLs) were shown to only bind at most half of neurons in hippocampal culture [10] .
We demonstrate that accumulation of exogenously added A␤ 1-42 occurs in certain, but not all, excitatory CamKII-positive neurons. We did not find any such accumulation in processes of inhibitory GAD67-positive neurons, supporting previous studies [10, 34] . Many factors may play a role in the affinity of A␤ binding and uptake in different types of neurons. A␤ has been proposed to interact with numerous different putative receptors, including among many others the PrP C receptor, metabotropic glutamate receptor 5 (mGluR5), a7 nicotinic acetylcholine receptor, immunoglobulin G Fc␥ receptor II-b (Fc␥RIIb), mouse paired immunoglobulin-like receptor B (PirB), leukocyte immunoglobulin-like receptor (LilrB2) and Ephrin-like B receptor 2 (EphB2) [35] [36] [37] [38] [39] [40] . In addition, A␤PP has been shown to be important in the binding [41] , toxicity [42, 43] and synapse altering effects of A␤ [6] .
Overall, the pattern of A␤ accumulation in neurons treated with exogenous A␤ appears to be more consistent with dendritic labeling compared to axonal. However, as dendrites are thicker than axons, the greater surface area might give the impression of more A␤ in dendrites, no matter whether it is due to "unspecific" binding and/or uptake via the plasma membrane or via a more regulated mechanism via one or several specific target molecules. Moreover, using two different sets of pre-and post-synaptic markers, we found no selective preference of exogenous A␤ 42 to either the pre-or post-synaptic side in cultured neurons. In contrast to our study, Lacor et al. [10] found that ADDLs colocalized with PSD-95. It is important to note that, colocalization analysis of A␤ with the pre-or post-synaptic site is very much dependent on the particular pre-or post-synaptic marker chosen to represent the synaptic sites. It is also likely that the concentration and conformation of A␤ will have an impact on the precise spatial targeting of added A␤ to synapses. Corroborating our results, a recent study showed endogenous non-fibrillar oligomeric A␤ within a subset of both pre-and post-synaptic sites in A␤PP/PS1 mouse brains (labeled with synaptophysin and PSD-95, respectively) by transmission electron microscopy and array tomography [44] . It has been suggested that A␤ might have differential effects on the pre-and post-synaptic sides and that this effect depends on the concentration of A␤ [45] . Within a physiological range, small increases in A␤ might primarily facilitate pre-synaptic functions, resulting in synaptic potentiation [46, 47] . However, at abnormally high levels, A␤ could enhance LTD-related mechanisms, resulting in post-synaptic depression and loss of dendritic spines [48, 49] .
As well as being endocytosed from the extracellular compartment, A␤ is also produced within neurons after ␥-secretase cleavage of A␤PP CTFs. Frykman et al. [50] reported the presence of active ␥-secretase in preparations of synaptic vesicles and pre-synaptic membranes of rat brain. Sannerud et al. [27] reported that PS2 was exclusively present in the somatodendritic compartments, while PS1 localized to both axons and dendrites. Here we show by immuno-gold EM that A␤PP CTF accumulation, due to lack of ␥-secretase cleavage, occurs mainly in post-synaptic compartments in the CA3 region of hippocampus in PS1 cKO; A␤PP Tg mice, while a previous report focusing on CA1 hippocampus described pre-synaptic accumulation [26] . This suggests an anatomical difference in the pre-versus post-synaptic ␥-secretase activity in the brain. As the axons of CA3 neurons terminate in the CA1 region, a possible explanation for our results could be that CA3 neurons have particularly high ␥-secretase cleavage of A␤PP. This would in PS1 cKO; A␤PP Tg mice leads to accumulation of A␤PP CTFs both in the axon Scale bars 500 nm. B) Immunofluorescent labeling of A␤PP/PS1 primary cortical neurons treated with the ␥-secretase inhibitor DAPT. A␤PP CTF-accumulation is seen by C-terminal specific A␤PP antibody 369 in both axons and dendrites after 17 h. However, with only 2 h of DAPT treatment, A␤PP CTF-accumulation is evident only in pre-synaptic compartments. Scale bars 50 m. C) Quantification of the intensity of antibody 369 labeling in post-synaptic compared to pre-synaptic compartments with DAPT-treatment indicates a relatively greater increase in pre-synapses, which is also evident earlier (at 2 h). Thresholds were set by automatic thresholding by default on confocal images in the MAP2 or tau-1 channel. The mean intensity of the antibody 369 channel was subsequently measured in the pixels that were above threshold in the MAP2 or tau-1 channel respectively. Values are presented as percentage of respective untreated control.
terminals of the CA3 neurons that terminate in presynaptic compartments in CA1 and in the dendrites of CA3 neurons in post-synaptic compartments of CA3. We also show by short term (2 h) treatment of chemical ␥-secretase inhibitor that A␤PP CTFs first and/or to a larger extent accumulate in pre-synaptic compartments in cortical neurons. However, after longer time points of DAPT treatment (17 h), A␤PP CTFs are also evident in post-synaptic compartments. This suggests that either (1) only a small fraction of neurons accumulates A␤PP CTFs in their post-synaptic compartments which is initially drowned out by most neurons not showing this, (2) a longer treatment duration being necessary to impact post-synaptic A␤PP CTFs, and/or that A␤PP CTFs first accumulate in presynaptic compartments that then only with time are transported to post-synaptic compartments. Another possible explanation of the preferential buildup of A␤PP CTFs in the pre-synaptic compartment with ␥-secretase inhibition could be faster degradation of A␤PP CTFs in the post-synaptic compartment compared to the pre-synaptic compartment. A␤PP CTFs have been shown to be degraded by the lysosome and since lysosomes are only found in the cell body of the neuron and not in the axon or dendrite, it appears less likely that the A␤PP CTFs are degraded in either the axon or the dendrites. An additional possibility is that retrograde transport of A␤PP CTF-containing multivesicular bodies to the cell body for degradation might be slower in axons compared to dendrites. However, vesicular trafficking of A␤PP bearing a C-terminal tag typically appears more rapid in axons than dendrites [6] .
AD is a complex disease of aging that is only gradually becoming better understood. The precise role of the A␤ peptide, which has been linked by pathological, genetic and biological lines of evidence to the disease, remains to be understood. Increasing evidence supports that like in other neurodegenerative diseases where synapses are sites of attack, the misfolding proteins linked to AD, A␤ and tau, also target synapses in this disease [8, 51] . How fundamental processes of aging make synapses vulnerable sites requires further work, although the wear and tear of synaptic activity and resulting oxidative, inflammatory, vascular and other stressors likely drive the vulnerabilities of synapses in age-related proteinopathies [52, 53] .
Here we underscore the challenges in clearly differentiating A␤ binding to pre-compared to postsynaptic compartments and highlight anatomical differences in accumulation of A␤PP metabolites.
Synapse loss is considered the best pathological correlate of cognitive deficits in human AD [2] . A␤ accumulates at synapses and is associated with synaptic pathology [9] and leads to loss of synaptic markers such as PSD-95, GluR1 and synaptophysin [54] . Hence a better understanding of the subcellular site of A␤ involvement within neurons in AD will be important to understand the selective vulnerability and anatomical specificity of AD.
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